Cryptocurrency Market Surges Across the Board, ETH Leads with 20.81% Increase, BTC Market Cap Ranks Among Top Five Global Assets
According to SoSoValue data, the cryptocurrency market has surged across the board, with 24-hour gains generally ranging from 5% to 20%. Among them, Ethereum (ETH) led the rise with a 20.81% increase, climbing above $2200. Bitcoin (BTC) rose 5.29% in 24 hours, briefly surpassing $104,000, returning to the $100,000 mark after three months, and its market value exceeded $2 trillion, surpassing Amazon to rank fifth in global asset market value.
Meanwhile, MAG7.ssi rose 9.23%, DEFI.ssi increased by 15.26%, and MEME.ssi went up by 15.07%.
Other standout sectors include: the Meme sector, which rose 15.57% in 24 hours, with OFFICIAL TRUMP (TRUMP) and Pepe (PEPE) rising 22.97% and 31.38% respectively; the AI sector increased by 15.49%, with Bittensor (TAO), Worldcoin (WLD), and Virtuals Protocol (VIRTUAL) rising 11.20%, 14.12%, and 47.81% respectively; the DeFi sector rose 13.57%, with Lido DAO (LDO), Ethena (ENA), and Uniswap (UNI) increasing by 20.45%, 24.36%, and 25.32% respectively; the NFT sector rose 12.82%, with Pudgy Penguins (PENGU) rising 20.05%.
Additionally, the Layer2 sector rose 11.63%, the Layer1 sector increased by 8.63%, and Cardano (ADA) rose 12.27%; the PayFi sector increased by 7.85%, and the CeFi sector rose 4.48%.
The crypto sector indices reflecting historical market trends show that the ssiNFT, ssiAI, and ssiGameFi indices rose by 15.47%, 14.48%, and 14.09% respectively in 24 hours.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Dollar Index falls to near 101.50 amid Fed rate pause odds, easing safe-haven demand

Utexo Mint open beta: Get early access to USD₮ on the bitcoin blockchain

"Demand destruction" and tug-of-war over Saudi attack risks, international oil prices fall more than 2%
Traders weighed the impact of Saudi attack risks and sharply reduced demand, causing oil prices to fall more than 2%.

JPMorgan maintains "Neutral" rating on Johnson & Johnson (JNJ.US): Strong data from two anti-cancer drugs, but valuation premium limits upside potential
Johnson & Johnson’s new prostate cancer drug and head and neck cancer drug Ervantumab both released positive data at ESMO. JPMorgan stated that the pipeline shows differentiated potential but valuations are relatively high, maintaining a Neutral rating.
